NEOGENOMICS INC Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Neogenomics Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Neogenomics Inc Return On Equity for the quarter ending September 30, 2024 was -8.43 %, a 15.2% increase year-over-year.
  • Neogenomics Inc annual Return On Equity for 2023 was -9.21 %, a 34.1% increase from 2022.
  • Neogenomics Inc annual Return On Equity for 2022 was -14 %, a 1673% decline from 2021.
  • Neogenomics Inc annual Return On Equity for 2021 was -0.79 %, a 219% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -9.21 +4.76 +34.1% Jan 1, 2023 Dec 31, 2023
2022 -14 -13.2 -1673% Jan 1, 2022 Dec 31, 2022
2021 -0.79 -1.45 -219% Jan 1, 2021 Dec 31, 2021
2020 0.66 -1.1 -62.4% Jan 1, 2020 Dec 31, 2020
2019 1.76 +0.66 +60% Jan 1, 2019 Dec 31, 2019
2018 1.1 +1.33 Jan 1, 2018 Dec 31, 2018
2017 -0.23 +2.95 +92.8% Jan 1, 2017 Dec 31, 2017
2016 -3.18 -0.59 -22.8% Jan 1, 2016 Dec 31, 2016
2015 -2.59 -5.33 -194% Jan 1, 2015 Dec 31, 2015
2014 2.74 -7.38 -72.9% Jan 1, 2014 Dec 31, 2014
2013 10.1 +9.42 +1334% Jan 1, 2013 Dec 31, 2013
2012 0.71 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.